Results 161 to 170 of about 8,841,562 (288)
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Exploring contemporary public perceptions of historical redlining practices in the United States. [PDF]
Lu Y +5 more
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
The Role of Gaze in Shaping Forms of Reflective Practice: A Legitimation Code Theory Analysis of Clinical Supervision in Danish Primary Care. [PDF]
Hindhede AL, Hald HH, Andersen C.
europepmc +1 more source
Evidence-based practice in autism educational research: can we bridge the research and practice gap?
Karen Guldberg
openalex +2 more sources
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
The 'shades of grey' in research integrity-Researchers admit to questionable research practices that they do not perceive to be serious. [PDF]
Entradas M, Feng Y, Sousa ICE.
europepmc +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Assessing Science Practices in Undergraduate Chemistry Laboratories: Why We Need to Do Betterand How We Should. [PDF]
Bapu Ramesh V, Seery MK, Cole R.
europepmc +1 more source

